We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BIOCARE CORP

BioCare Corporation manufactures and markets medical devices such as electrolyte analyzer, urine analyzer, hospital-g... read more Featured Products: More products

Download Mobile App




Fully Open Automated Slide Staining Instrument Designed for Robust Antibody Staining

By LabMedica International staff writers
Posted on 07 Dec 2023
Print article
Image: intelliPATH+ is the next-generation enhancement of the proven intelliPATH FLX staining system (Photo courtesy of Biocare Medical)
Image: intelliPATH+ is the next-generation enhancement of the proven intelliPATH FLX staining system (Photo courtesy of Biocare Medical)

An advanced staining instrument with state-of-the-art upgrades has been designed for ultimate flexibility and robust antibody staining with rich features for enhanced laboratory usability.

Biocare Medical (Pacheco, CA, USA) has introduced the intelliPATH+ advanced staining instrument, a newly upgraded system featuring the latest technological advancements. This fully open system allows for continuous random access along with immediate STAT capabilities, enhancing the workflow significantly. It is particularly efficient in immunohistochemistry (IHC) staining, providing increased speed, superior quality, and reduced waste. The intelliPATH+ is tailor-made for lab professionals who value the dependability of automated processes but require flexibility for specific needs. It features customizable protocols for each of its 50 slide positions, promoting both precision and efficiency.

The intelliPATH+ boasts a redesigned, scalable user interface that makes laboratory workflow more efficient. This user-friendly interface allows easy navigation with options for pre-set protocols or custom creation, including adjustable dispense volumes from 100µl to 600µl across three different zones. This customization ensures an efficient and personalized staining experience. The system meticulously controls every aspect of the staining process. When combined with Biocare Medical’s latest ARC decloaking chamber, it delivers robust, reproducible, and vivid staining results.

The ARC, specifically designed for Heat-Induced Epitope Retrieval (HIER) and compliant with in vitro diagnostic (IVD) standards, is indispensable for high-quality IHC and in situ hybridization (ISH) staining. It can hold up to 72 standard slides or 27 double-wide slides, offering a broad temperature range from 60°C to 121°C. This capability makes the ARC a crucial tool for both clinical and research settings, ensuring accurate and consistent results. The intelliPATH+, now labeled for IVD use, is available for purchase in the United States and selected international markets.

Related Links:
Biocare Medical

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultra-Low Temperature Freezer
iUF118-GX
New
Pipet Controller
Stripettor Pro

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.